Wyeth Sues Watson Over Birth Control Patent
Wyeth has filed suit against Watson Pharmaceuticals Inc., claiming the generic-drug maker infringed a patent for its birth control drug Lybrel by submitting an abbreviated new drug application to the U.S....To view the full article, register now.
Already a subscriber? Click here to view full article